FDA-Drug2026-08-26Class IIPROCESSING DEFECT

American Regent Atropine Sulfate injection recalled for particulate contamination

GLASSOTHERNationwide distributionDrugs

What this means

American Regent's Atropine Sulfate injection (1 mg/mL) has been found to contain particulate matter, including hair, glass, and/or paraformaldehyde. The contamination affects specific lot 24353 (expiration 9/30/2026). This is a prescription injectable medication used in hospitals and clinical settings.

  • If you dispense or administer this medication, check your inventory for lot 24353 with expiration 9/30/2026.
  • Do not use vials from this lot.
  • Contact American Regent or your supplier for return or replacement instructions.
  • Notify your pharmacy, hospital, or medical facility if you have received vials from this lot.
Get recalls like this in a free plain-English brief every Sunday.Get alerts ↓
The agency's original wording
Hazard

Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde

Intended for
Adults
Illnesses reported
None reported
Sold states
Nationwide within the U.S
Affected count
89,775 vials
Manufactured in
5 Ramsay Rd, Shirley, NY, United States
Products
Atropine Sulfate injection, USP, 1 mg/mL, For intravenous Use, Sterile, packaged in a) 1 mL Single-Dose Vial (NDC 0517-1001-01), and b) 25x1 mL Single-Dose Vial (NDC 0517-1001-25), Rx only, AMERICAN REGENT INC., SHIRLEY, NY 11967.

Official notice

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0795-2026

More American Regent recalls

Want us to check the next one for you?

We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.

Free · One email a week · Unsubscribe anytime
By signing up you agree to our Terms and Privacy Policy.